|
ALT Altimmune Inc 1326190 |
| Balance Sheet |
|
Current Assets
|
137,254,000 |
|
Assets
|
139,306,000 |
|
Current Liabilities
|
10,468,000 |
|
Liabilities
|
15,798,000 |
|
Equity
|
123,508,000 |
|
Shares Out
|
71,071,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-79,848,000 |
|
Investing Cash Flow
|
-28,386,000 |
| Market Analysis |
Market Cap
|
474,043,175 |
|
Price
|
5.71 |
|
BVPS
|
1.74 |
|
PB
|
3.33 |
|
EPS
|
-1.62 |
|
PS
|
5925.54 |
|
FCF
|
-108,234,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/27 |
-1.34 |
|
0.62 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALT documents filed with the SEC.
ALT Filings
Clear
